Abstract
Safety assessment of probiotic Lactobacillus fermentum MTCC-5898 (LF) with three doses (107, 109, and 1011 cfu/day/animal) was carried on Swiss albino mouse weanlings for 28 days using oral route. Health status of animals was monitored by physical assessment of body weight, organ indices, and histological appearances of liver and intestine along with measurement of hematological parameters (Hb, WBC, RBC count, MCHC, MCV, MCH), biochemical analytes in blood involving glucose, serum enzymes (ALT, AST and LDH), urea, creatinine, and lipid profile (total cholesterol, triglycerides, HDL, VLDL, LDL, and atherogenic index). LF showed no adverse effects on above parameters of general health status after continuous consumption for the experimental period. On the other hand, significant increase (p ≤ 0.05) in TGF-β (regulatory cytokine) and considerable decrease (p ≤ 0.05) in IFN-γ (pro-inflammatory cytokine) without any major changes in IL-4 and IL-12 in intestinal fluid on consumption of 109 cfu/animal/day confirmed its dose-specific response for immune homeostasis. Further, safety of LF was also confirmed by insignificant changes in release of FITC-dextran (4 kDa) in blood on its consumption than control group where only saline was given orally. Moreover, significantly (p ≤ 0.05) increased mRNA expression of claudin-1 and MUC-2 in intestinal epithelial cells on feeding L. fermentum further supported FITC-dextran permeability data which otherwise showed increased flux of FITC-dextran in blood on consumption of E. coli (109 cfu/animal/day) due to intestinal damage. Thus, in vivo results confirmed that Lactobacillus fermentum MTCC 5898 is safe and non-toxic to weanling mice and may be considered for functional food application after clinical testing.
Similar content being viewed by others
References
Sekirov I, Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
Fijan S (2014) Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health 11:4745–4767
Bernardo WM, Aires FT, Carneiro RM, de Sa FP, Rullo VE, Burns DA (2013) Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. J Pediatr (Versão em Português) 89:18–24
Khalesi S, Sun J, Buys N, Jayasinghe R (2014) Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 64:897–903
Doron S, Snydman DR (2015) Risk and safety of probiotics. Clin Infect Dis 60:129–134
Hanlon PR, Frestedt J, Magurany K (2017) GRAS from the ground up: review of the interim pilot program for GRAS notification. Food Chem Toxicol 105:140–150
Hojsak I, Shamir R (2013) Safety of probiotics. In Probiotic bacteria and their effect on human health and well-being . Karger, Basel, pp 161–170
Metchnikoff E, Metchnikoff II, Mitchell PC (1908) The prolongation of life: optimistic studies. GP Putnam's Sons, New York, USA
Ganguly NK, Bhattacharya SK, Sesikeran B, Nair GB, Ramakrishna BS, Sachdev HP, Batish VK, Kanagasabapathy AS, Muthuswamy V, Kathuria SC, Katoch VM (2011) ICMR-DBT guidelines for evaluation of probiotics in food. Indian J Med Res 134:22
Sharma R, Kapila R, Kapasiya M, Saliganti V, Dass G, Kapila S (2014) Dietary supplementation of milk fermented with probiotic Lactobacillus fermentum enhances systemic immune response and antioxidant capacity in aging mice. Nutr Res 34:968–981
Yadav R, Khan SH, Mada SB, Meena S, Kapila R, Kapila S (2018) Consumption of probiotic Lactobacillus fermentum MTCC: 5898-fermented milk attenuates dyslipidemia, oxidative stress, and inflammation in male rats fed on cholesterol-enriched diet. Probiotics Antimicrob Proteins 13:1–10
Yadav R, Dey DK, Vij R, Meena S, Kapila R, Kapila S (2018) Evaluation of anti-diabetic attributes of Lactobacillus rhamnosus MTCC: 5957, Lactobacillus rhamnosus MTCC: 5897 and Lactobacillus fermentum MTCC: 5898 in streptozotocin induced diabetic rats. Microb Pathog 125:454–462
Lim TS, Messiha N, Watson RR (1981) Immune components of the intestinal mucosae of ageing and protein deficient mice. Immunology 43:401
Yatzidis H (1960) Measurement of transaminases in serum. Nature 186:79–80
Bergmeyer HU, Gawehn K (1978) Principles of enzymatic analysis. Verlag Chemie, NewYork
Uchiyama M, Mihara M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271–278
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B (2015) Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods 421:44–53
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25:402–408
Festing MF, Altman DG (2002) Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 43:244–258
Charan J, Kantharia ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4:303–306
Basha S, Surendran N, Pichichero M (2014) Immune responses in neonates. Expert Rev Clin Immunol 10:1171–1184
Perry P (2007) The ethics of animal research: a UK perspective. ILAR J48:42–46
Stevenson RD, Woods WA Jr (2006) Condition indices for conservation: new uses for evolving tools. Integr Comp Biol 46:1169–1190
Kabeir BM, Yazid AM, Stephenie W, Nazrul Hakim M, Muhammad Anas O, Shuhaimi M (2008) Safety evaluation of Bifidobacterium pseudocatenulatum G4 as assessed in BALB/c mice. Lett Appl Microbiol 46:32–37
Petterino C, Argentino-Storino A (2006) Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp Toxicol Pathol 57:213–219
Serfilippi LM, Stackhouse Pallman DR, Russell B, Spainhour CB (2003) Serum clinical chemistry and hematology reference values in outbred stocks of albino mice from three commonly used vendors and two inbred strains of albino mice. J Am Assoc Lab Anim 42:46–52
Ihedioha JI, Ugwuja JI, Noel-Uneke OA, Udeani IJ, Daniel-Igwe G (2012) Reference values for the haematology profile of conventional grade outbred albino mice (Mus musculus) in Nsukka, eastern Nigeria. Anim Res Int 9:1601–1612
Park JH, Lee YE, Moon EN, Seok SH, Baek MW, Lee HY, Kim DJ, Kim CH, Park JH (2005) Safety assessment of Lactobacillus fermentum PL9005, a potential probiotic lactic acid bacterium, in mice. J Microbiol Biotechnol 15:603–608
Lara-Villoslada F, Sierra S, Diaz-Ropero MP, Rodriguez JM, Xaus J, Olivares M (2009) Safety assessment of Lactobacillus fermentum CECT5716, a probiotic strain isolated from human milk. J Dairy Res 76:216–221
FAO/WHO (2001) Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria; food and agriculture Organization of the United Nations and World Health Organization Expert Consultation Report, Rome
Gowda S, Desai PB, Hull VV, Math AA, Vernekar SN, Kulkarni SS (2009) A review on laboratory liver function tests. Pan Afr Med J 3:17
Sher Y, Hung M (2013) Blood AST, ALT and UREA/BUN level analysis. Bio-Protocol 3:931
Suckow MA, Brayton C, Danneman P (2001) The laboratory mouse. CRC, Boca Raton, Florida
Mazzaccara C, Labruna G, Cito G, Scarfo M, De Felice M, Pastore L, Sacchetti L (2008) Age-related reference intervals of the main biochemical and hematological parameters in C57BL/6J, 129SV/EV and C3H/HeJ mouse strains. PLoS One 3:3772
Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, Li Y (2016) Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol 16:62
Ouwehad AC (2016) A review of dose-responses of probiotics in human studies. Benefic Microbes 8:143–151
Giannini EG, Testa R, Savarino V (2005) Liver enzyme alteration: a guide for clinicians. Can Med Assoc J 72:367–379
Corbett JV (2008) Laboratory tests and diagnostic procedures with nursing diagnoses. San Francisco, California
Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AA, Vernekar SN (2010) Markers of renal function tests. N Am J Med Sci 2:170
Zhang H, Sun J, Wang QY, He YT, Gu HY, Guo HY, Ding QB, Yang JS, Ren FZ (2013) Safety assessment of Lactobacillus salivarius REN, a probiotic strain isolated from centenarian feces. J Food Sci Technol 19:1037–1043
Del Rio D, Stewart AJ, Pellegrini N (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15:316–328
Farmer EE, Davoine C (2007) Reactive electrophile species. Curr Opin Plant Biol 10:380–386
Kapila S, Sinha P (2006) Antioxidative and hypocholesterolemic effect of Lactobacillus casei ssp casei (biodefensive properties of lactobacilli). Indian J Med Sci 60:361–370
Aguilar EC, Queiroz MD, Oliveira DA, Oliveira NJ (2011) Serum lipid profile and hepatic evaluation in mice fed diet containing Pequi nut or pulp (Caryocar brasiliense Camb.). Food Sci Technol 31:879–883
Santos EW, de Oliveira DC, Hastreiter A, da Silva GB, de Oliveira Beltran JS, Tsujita M, Crisma AR, Neves SM, Fock RA, Borelli P (2016) Values of hematological and biochemical reference for mice from the C57BL / 6, Swiss Webster and BALB/c lines. Braz J Vet Res Anim 53:38–145
Baroutkoub Baroutkoub A, Mehdi RZ, Beglarian R, Hassan J, Zahra S, Mohammad MS (2010) Effects of probiotic yoghurt consumption on the serum cholesterol levels in hypercholestromic cases in shiraz, southern Iran. Sci Res Essays 5:2206–2209
Shadnoush M, Hosseini RS, Mehrabi Y, Delpisheh A, Alipoor E, Faghfoori Z, Mohammadpour N, Moghadam JZ (2013) Probiotic yogurt affects pro-and anti-inflammatory factors in patients with inflammatory bowel disease. Iran J Pharm Res 12:929
Volynets V, Rings A, Bárdos G, Ostaff MJ, Wehkamp J, Bischoff SC (2016) Intestinal barrier analysis by assessment of mucins, tight junctions, and α-defensins in healthy C57BL/6J and BALB/cJ mice. Tissue Barriers 4:1208468
Kumar M, Kissoon-Singh V, Coria AL, Moreau F, Chadee K (2016) Probiotic mixture VSL# 3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. Am J Physiol Gastrointest Liver Physiol 312:34–45
Gotteland M, Cruchet S, Verbeke S (2001) Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans. Aliment PharmacolTher 15:11–17
Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M (2009) Probiotic mixture VSL# 3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296:1140–1149
Hsieh CY, Osaka T, Moriyama E, Date Y, Kikuchi J, Tsuneda S (2015) Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum. Phys Rep 3:12327
Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC (2010) Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 10:316
Acknowledgments
The authors acknowledge ICAR-National Dairy Research Institute (NDRI) Karnal for providing laboratory facilities to carry out the present work.
Funding
The Department of BioTechnology, Ministry of Science and Technology, New Delhi provided funds (BT/PR15109/PFN/20/1174/2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The animal trials were conducted after the approval of the institutional animal ethics committee (ICAR-NDRI: Approval no. 41-IAEC-18-59 dated January 27, 2018).
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Samtiya, M., Bhat, M.I., Gupta, T. et al. Safety Assessment of Potential Probiotic Lactobacillus fermentum MTCC-5898 in Murine Model after Repetitive Dose for 28 Days (Sub-Acute Exposure). Probiotics & Antimicro. Prot. 12, 259–270 (2020). https://doi.org/10.1007/s12602-019-09529-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12602-019-09529-6